Equities
  • Price (EUR)1.72
  • Today's Change0.044 / 2.63%
  • Shares traded1.40k
  • 1 Year change-16.96%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024 18:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ping AN Healthcare and Technology Co Ltd is a company mainly engaged in the provision of medical and health services through mobile platforms and offline resources. The Company conducts its business through two segments. The Medical Services segment is mainly engaged in online consultation, hospital referral and appointment, inpatient arrangement, diagnosis and treatment of diseases and related pharmaceuticals and medical devices sales. The Health Services segment provides a variety of standardized health service packages that integrate services from medical and health institutions to meet users' health-related needs, covering multiple categories and service forms such as physical examination, elderly care, dental, anti-aging and general health.

  • Revenue in HKD (TTM)4.89bn
  • Net income in HKD-22.94m
  • Incorporated2014
  • Employees1.45k
  • Location
    Ping AN Healthcare and Technology Co Ltd5-8/F, Building B, INNO KICNo. 298 Guo Xia Road, Yangpu DistrictSHANGHAI ChinaCHN
  • Websitehttps://www.pagd.net/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.